Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ACAD
TMDX
Add up to 3 more stocks
ACAD
Acadia Pharmaceuticals Inc.
-0.35%
$20.04-0.07Delayed quote: Oct 6, 2026, 11:05 AM EDT
Market Cap
$3.43B
52W Range
$19.57 - $30.96
TMDX
TransMedics Group, Inc.
-2.16%
$81.20-1.79Delayed quote: Oct 6, 2026, 11:05 AM EDT
Market Cap
$2.81B
52W Range
$60.10 - $156.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 9.03 | 21.04 |
| Forward P/E | 32.53 | 55.35 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.63 | 5.42 |
| P/S Ratio | 3.01 | 4.20 |
| P/FCF Ratio | 19.68 | 35.50 |
| EV/EBITDA | 31.71 | 27.12 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 91.1% | 58.7% |
| Operating Margin | 7.6% | 12.2% |
| Net Margin | 33.4% | 22.7% |
| ROE | 29.1% | 29.3% |
| ROA | 21.8% | 10.4% |
| ROIC | 6.3% | 5.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.39 | 6.62 |
| Quick Ratio | 3.30 | 6.07 |
| Debt/Equity | 0.06 | 1.67 |
| Interest Coverage | N/A | 7.88 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.